Meet the One Million Strong – Sandy Muschenheim from Minnesota

MEET SANDY Sandy Muschenheim St. Paul, Minnesota Sandy’s Story I was diagnosed with stage III colon cancer during my baseline screening colonoscopy in 2011. My first liver metastasis was removed one year later.  I have had additional liver metastases removed in 2013 and 2015. I…

Read Full Post

Treating Liver Metastases Webinar Available Online

On Monday, May 16th, 2011, Dr. Andrew Kennedy, a well-known researcher in liver metastases, led a Fight Colorectal Cancer webinar discussing an issue that affects thousands of colorectal cancer patients. Colorectal cancer often metastasizes first to the liver, so learning how to manage growth of…

Read Full Post

Upcoming Patient Webinars Will Bring the Science to YOU

Fight Colorectal Cancer is giving you the opportunity to talk to researchers and medical professionals in April and May through online webinars designed to bring the science of treating colorectal cancer down to the personal. The latest news from the petri dish Wednesday, April 20,…

Read Full Post

KRAS Mutations Match in Almost All Tumors

If there is a KRAS mutation in the primary colon or rectal tumor, there is almost always a matching mutation when that tumor spreads to the liver. Researchers in the Netherlands tested both tumors for KRAS mutations in over 300 patients whose cancer had spread…

Read Full Post

Clinical Trial at NIH for Unresectable Liver Tumors

Patients with liver tumors, including those that have spread from colorectal cancer, can enroll in a clinical trial at the National Institutes of Health Clinical Center in Bethesda. The trial will test the effectiveness of infusing the drug melphalan through the artery that feeds the…

Read Full Post

Young Patients Do Worse After Surgery for Liver Mets

Patients under 40 appear to have more aggressive liver tumors from colorectal cancer and poorer long-term outcomes. After surgery to remove the cancer that had spread to their liver, patients who were 40 or younger had poorer overall survival and shorter time until cancer returned….

Read Full Post

C3 Advocates Contribute to RFA Effectiveness Review

How useful is radiofrequency ablation (RFA) in treating liver metastases from colorectal cancer? To answer that question, American Society for Clinical Oncology scientists included two C3 advocates, Rob Michelson and Dr. Andrew Guisti, on an expert panel looking at published RFA research. In appreciation, the…

Read Full Post

Talking to Your Doctor about Liver Mets

What should you and your doctor talk about if your colon or rectal cancer has spread to your liver? Deciding on the best way to manage liver metastases from colorectal cancer isn’t easy. It’s best done with the involvement of  multidisciplinary team of doctors and…

Read Full Post

Patient Outcomes Vary Depending on Liver Resectability

Patients with stage IV colorectal cancer live longer when tumors in their liver can be removed surgically, but not all patients have cancer that can be operated on. Separating patients with liver tumors from colorectal cancer into three groups according to possible liver resectability, British…

Read Full Post

Erbitux Plus Chemo Can Make Liver Mets Surgery Possible

Chemotherapy and Erbitux® (cetuximab) reduced liver tumors from colorectal cancer enough for patients to have them removed surgically. Although their cancer was initially too extensive to be surgically removed (resected) chemotherapy combined with Erbitux allowed about a third of patients to have surgery that completely…

Read Full Post
Page 1 of 3123